SEPTIN9 and colorectal carcinoma: Moreover, in 2016, the Food and Drug Administration approved a blood test to detect circulating methylated SEPT9 DNA (https://www.accessdata.fda.gov/cdrh_docs/pdf13/p130001c.pdf) with a low sensitivity (48%) for detecting CRC (22).